Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

XENON XE-133 GAS DIN 02328747

Status: Cancelled Pre Market
Holder: BRISTOL-MYERS SQUIBB CANADA
Molecule: XENON

Health Canada record

Active ingredient(s)XENON 133 XE 150 MCI
Dosage formGas
RouteInhalation
ScheduleSCHEDULE C
ClassRadiopharmaceutical
ATC
Original market date
Current status date29-Sep-2022
SourceHealth Canada DPD

Establishment licence of the holder

Bristol-Myers Squibb Canada — licence 100100, currently licensed, last inspection rating C (2026-03-18).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing XENON

DINProductCompanyFormStrengthStatus
02360268DRAXIMAGE XENON XE 133JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMAGasXENON 133 XE 370 MBqCancelled Post Market
02360276DRAXIMAGE XENON XE 133JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMAGasXENON 133 XE 740 MBqCancelled Post Market
02327880XENONLANTHEUS MI CANADA INCGasXENON 133 XE 10 MCICancelled Pre Market
02327899XENONLANTHEUS MI CANADA INCGasXENON 133 XE 20 MCICancelled Pre Market
02014386XENON OXYGEN USP MEDICAL GAS MIXTUREPRAXAIR CANADA INCGasXENON 133 XE 35 %; OXYGEN 65 %Cancelled Post Market

International API supply for XENON

3 active FDA Drug Master Files.

Request a quote for XENON XE-133 GAS

How to read a Canadian DIN record